Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point
Ndhlovu ZM., Ndhlovu ZM., Kamya P., Kamya P., Mewalal N., Kløverpris HN., Kløverpris HN., Nkosi T., Pretorius K., Laher F., Ogunshola F., Chopera D., Shekhar K., Ghebremichael M., Ismail N., Moodley A., Moodley A., Malik A., Leslie A., Leslie A., Goulder PJR., Goulder PJR., Buus S., Chakraborty A., Chakraborty A., Dong K., Ndung'u T., Ndung'u T., Ndung'u T., Ndung'u T., Walker BD., Walker BD., Walker BD.
© 2015 Elsevier Inc. CD8+ Tcells contribute to the control of HIV, but it is not clear whether initial immune responses modulate the viral set point. We screened high-risk uninfected women twice a week for plasma HIV RNA and identified 12 hyperacute infections. Onset of viremia elicited a massive HIV-specific CD8+ Tcell response, with limited bystander activation of non-HIV memory CD8+ Tcells. HIV-specific CD8+ Tcells secreted little interferon-γ, underwent rapid apoptosis, and failed to upregulate the interleukin-7 receptor, known to be important for Tcell survival. The rapidity to peak CD8+ Tcell activation and the absolute magnitude of activation induced by the exponential rise in viremia were inversely correlated with set point viremia. These data indicate that rapid, high magnitude HIV-induced CD8+ Tcell responses are crucial for subsequent immune control of acute infection, which has important implications for HIV vaccine design. The relationship between onset of HIV viremia and CD8+ Tcell responses is not well defined. Walker and colleagues screened high-risk uninfected women to identify cases of hyperacute infection, and show that the magnitude and kinetics of initial HIV-specific CD8+ Tcell responses are associated with subsequent control of viremia.